Trials / Sponsors / Chinook Therapeutics, Inc. (formerly Aduro)
Chinook Therapeutics, Inc. (formerly Aduro)
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer | Phase 2 | 2019-08-26 |
| Terminated | Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or L Advanced/Metastatic Solid Tumors or Lymphomas | Phase 1 | 2016-04-28 |